In conclusion, we have demonstrated that low expression of miR-203 was related to tumor recurrence and poor survival in early-stage HCC patients who underwent curative surgery, but ZEB1 did not show any prognostic significance in our cohort. The gene discussed is ZEB1; the disease is hepatocellular carcinoma.